NUROFEN RECOVERY (纽络芬去痛片) Please read these instructions carefully before you take this medicine. Nurofen Recovery dissolves

admin2014-07-10  38

问题                         NUROFEN RECOVERY (纽络芬去痛片)
    Please read these instructions carefully before you take this medicine. Nurofen Recovery dissolves (溶解) quickly on the tongue without the need to use water. It delivers effective relief from headaches.
    You should not take Nurofen Recovery if:
    -- you have had an allergic (过敏的) reaction to aspirin (阿司匹林)
    -- you have had a worsening of asthma (哮喘) when taking aspirin or similar medicines
    -- you are under 12 years of age
    Administration:
    Place a tablet on the tongue, allow it to dissolve and then swallow - - no water is required.
    Adults, the elderly and children of 12 years and older:
    Take 2 tablets, then if necessary, take 1 or 2 tablets every 4 hours. Do not exceed 6 tablets in 24 hours. Not suitable for children under 12 years.
    Warnings:
    If you take too many tablets by mistake, contact your doctor as soon as possible.
    If symptoms persist or if new symptoms occur, consult your doctor.
    Possible side effects:
    Stomach discomfort or pain, worsening of asthma or shortness of breath. If you experience any of these, stop taking the tablets and see your doctor.

                               NUROFEN RECOVERY
Function: delivering  【46】   from headaches
Feature: dissolving quickly on  【47】
People not intended for:  1) patients with an allergic reaction to aspirin
                          2) patients having asthma when taking aspirin
                          3) children under the age of 【48】
Dosage: 1) Starting Dose: 2 tablets
        2) If necessary: take 1 or 2 tablets  【49】
        3) Maximum daily intake: 6 tablets
Possible side effects:  1) stomach discomfort
                        2) worsening of asthma
                        3)  【50】

选项

答案effective relief

解析 在“It delivers effective relief from headaches.”这句话里直接告诉了我们答案。
转载请注明原文地址:https://jikaoti.com/ti/QApMFFFM
0

最新回复(0)